These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 2894891

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Purification and characterization of a novel transforming growth factor.
    Halper J, Moses HL.
    Cancer Res; 1987 Sep 01; 47(17):4552-9. PubMed ID: 2887280
    [Abstract] [Full Text] [Related]

  • 3. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K, Hudgins WR.
    Cancer Res; 1986 Nov 01; 46(11):6004-10. PubMed ID: 3019543
    [Abstract] [Full Text] [Related]

  • 4. Separation of transforming growth factors TGF alpha and TGF beta during chromatographic purification of extracts from mouse C-234 tumors.
    Popik W.
    Arch Immunol Ther Exp (Warsz); 1987 Nov 01; 35(6):839-51. PubMed ID: 3508041
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factors in solid human malignant neoplasms.
    Nickell KA, Halper J, Moses HL.
    Cancer Res; 1983 May 01; 43(5):1966-71. PubMed ID: 6299535
    [Abstract] [Full Text] [Related]

  • 6. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA, Klos DJ, Grant GA.
    Cancer Res; 1986 Oct 01; 46(10):5153-61. PubMed ID: 3489522
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Partial purification of transforming growth factors from human milk.
    Zwiebel JA, Bano M, Nexo E, Salomon DS, Kidwell WR.
    Cancer Res; 1986 Feb 01; 46(2):933-9. PubMed ID: 3000589
    [Abstract] [Full Text] [Related]

  • 9. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
    Stromberg K, Hudgins WR, Fryling CM, Hazarika P, Dedman JR, Pardue RL, Hargreaves WR, Orth DN.
    J Cell Biochem; 1986 Feb 01; 32(4):247-59. PubMed ID: 3492500
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK.
    Cancer Res; 1988 Jul 15; 48(14):3898-904. PubMed ID: 3164252
    [Abstract] [Full Text] [Related]

  • 11. Growth factor production by human colon carcinoma cell lines.
    Anzano MA, Rieman D, Prichett W, Bowen-Pope DF, Greig R.
    Cancer Res; 1989 Jun 01; 49(11):2898-904. PubMed ID: 2541895
    [Abstract] [Full Text] [Related]

  • 12. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS, Zwiebel JA, Bano M, Losonczy I, Fehnel P, Kidwell WR.
    Cancer Res; 1984 Sep 01; 44(9):4069-77. PubMed ID: 6331663
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anchorage-independent growth-conferring factor production by rat mammary tumor cells.
    Zwiebel JA, Davis MR, Kohn E, Salomon DS, Kidwell WR.
    Cancer Res; 1982 Dec 01; 42(12):5117-25. PubMed ID: 6291748
    [Abstract] [Full Text] [Related]

  • 15. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS, Perroteau I, Kidwell WR, Tam J, Derynck R.
    J Cell Physiol; 1987 Mar 01; 130(3):397-409. PubMed ID: 3494020
    [Abstract] [Full Text] [Related]

  • 16. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
    Arteaga CL, Hanauske AR, Clark GM, Osborne CK, Hazarika P, Pardue RL, Tio F, Von Hoff DD.
    Cancer Res; 1988 Sep 01; 48(17):5023-8. PubMed ID: 3165707
    [Abstract] [Full Text] [Related]

  • 17. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
    Tucker RF, Volkenant ME, Branum EL, Moses HL.
    Cancer Res; 1983 Apr 01; 43(4):1581-6. PubMed ID: 6299525
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.
    Coffey RJ, Goustin AS, Soderquist AM, Shipley GD, Wolfshohl J, Carpenter G, Moses HL.
    Cancer Res; 1987 Sep 01; 47(17):4590-4. PubMed ID: 2887281
    [Abstract] [Full Text] [Related]

  • 19. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
    Yamada Y, Serrero G.
    J Cell Physiol; 1989 Aug 01; 140(2):254-63. PubMed ID: 2663884
    [Abstract] [Full Text] [Related]

  • 20. Bifunctional activity of transforming growth factor type beta on the growth of NRK-49F cells, normal and transformed by Kirsten murine sarcoma virus.
    Jullien P, Berg TM, de Lannoy C, Lawrence DA.
    J Cell Physiol; 1988 Jul 01; 136(1):175-81. PubMed ID: 2840442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.